Explore

Capbase

Spine BioPharma, Inc. — Funding, Investors & Profile — Capbase

Private

Private securities offering disclosed via SEC Form D.

Pharmaceuticals

$384.8KSource: [SEC]Total raised

UndisclosedSource: [SEC]Last valuation

Spine BioPharma, Inc. filed a Form D notice of exempt offering with the SEC.

1 rounds

No investors recorded yet for Spine BioPharma, Inc..

Leadership

Marc R. ViscogliosiExecutive Officer · Director and Chief Executive Officer of the IssuerSince 2026Source: [SEC]

Fran MageeExecutive Officer · Chief Technology OfficerSince 2026Source: [SEC]

Showing 2 of 5 — any approved contribution unlocks every profile for 30 days.Sign in to unlock

Spine BioPharma, Inc. has no recorded acquisitions.

Still private — no exit on record.

No diversity signals recorded yet for Spine BioPharma, Inc..

Data aggregated from SEC EDGAR, Wikidata, and community contributions. Spotted an error? Propose a change or report an issue.